MALCOVA’s journey began with a critical observation: existing breast cancer imaging technologies fell short for women with dense breast tissue, leaving a significant gap in early cancer detection. “There’s a major unmet need in breast cancer imaging,” shared Ghazi. “Our company was founded when the perfect alignment of that need met a groundbreaking innovation in imaging technology.” Ghazi originally supported the company in a limited role while working full-time elsewhere. Seeing MALCOVA’s transformative potential, she soon committed fully, becoming a Co-Founder. “I became completely committed when I saw the potential for real clinical impact,” she recalled.